TOOTH REGENERATION MARKET ANALYSIS

Tooth Regeneration Market Size and Trends

Global tooth regeneration market is estimated to be valued at USD 5.10 Bn in 2024 and is expected to reach USD 7.71 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031.

Discover market dynamics shaping the industry: Request sample copy

The tooth regeneration market is witnessing positive growth trends. The increasing prevalence of dental caries and other associated dental diseases globally is driving the demand for tooth regeneration treatment methods. Additionally, the rising dental tourism industry in emerging markets is providing impetus to research and development activities in this market. With ongoing clinical trials showing promise, industry players are investing more in technologies leveraging stem cells, biomaterials, and tissue engineering for natural tooth regeneration. This is expected to make tooth regeneration a mainstream treatment option in the near future.

Rising prevalence of dental disorders

The increasing reliance on tooth regeneration solutions for diagnostic purposes has been a key factor boosting the tooth regeneration market. With the rapid rise in chronic and infectious diseases worldwide over the past decade, clinical laboratories have faced significant workload and operational challenges to provide timely diagnoses for patients. The tooth regeneration market is propelled by several key factors, including the escalating incidence of dental disorders, rapid advancements in regenerative medicine, and the expanding elderly population. For instance, according to the WHO Global Oral Health Status Report released in March 2023, oral diseases impact approximately 3.5 billion individuals worldwide, with three-quarters of affected individuals residing in middle-income countries. Globally, an estimated 2 billion people suffer from permanent tooth caries, while 514 million children are afflicted with primary tooth issues. The prevalence of major oral diseases continues to surge globally due to increasing urbanization and shifts in living conditions. Consequently, with a substantial portion of the population affected by oral health problems, there is a growing demand for effective and innovative dental treatments, including tooth regeneration technologies, to combat dental health challenges.

Market Concentration and Competitive Landscape

Get actionable strategies to beat competition: Request sample copy

Advancements in regenerative medicine and material science

Advancements in regenerative medicine and material science have opened up pathways for tooth regeneration solutions. Scientists have made significant progress in understanding the biological processes involved in tooth development. Researchers are now able to culture and grow replacement teeth from stem cells in the lab that mimic natural tooth development. This promises to significantly transform dental care by enabling true tooth regeneration and replacement of lost or damaged teeth.

Several regenerative dentistry companies are developing novel proprietary material scaffolds that can support the regrowth of dental tissues from a patient's own cells. These biomaterials are designed to encourage cellular reattachment and neurovascular ingrowth. They promote re-growth of dentin, root and enamel tissues for functional tooth replacement. Successful human trials have been reported where replacement teeth have been regenerated and implanted. For example, a 2021 clinical trial at a U.K. university teaching hospital demonstrated that lab-grown replacement teeth implanted in subjects had fully integrated within the jaw with normal pulp tissue regeneration and blood vessel formation after 12 months.

 Key Takeaways of Analyst:

The tooth regeneration market shows promising growth potential over the coming years. Driven by the rising prevalence of dental diseases worldwide and growing awareness about oral healthcare, the demand for tooth regeneration solutions is expected to increase substantially. Additionally, the growing geriatric population who are more prone to tooth loss will further drive market expansion.

North America currently dominates the tooth regeneration market and is likely to continue its leadership stance supported by well-established healthcare systems and rising expenditure on dental care in the region. However, Asia Pacific is projected to witness the fastest growth during the forecast period. This can be attributed to rising incomes, growing focus on healthcare, and increasing patient population in the developing countries of Asia Pacific.

While improved reimbursement and funding scenarios in major markets will augment the demand, limitations in current technology could restrict faster adoption rates. High costs involved in dental stem cell therapies and lack of skilled professionals poses notable challenges. Also, ethical issues related to the use of stem cells may hamper research progress to some extent.

Market Challenges: High cost of treatment procedures

The high cost of treatment procedures is a major factor restraining the growth of the tooth regeneration market. Dental treatments and regenerative procedures such as dental implants, bone grafts, and guided tissue regeneration are often very expensive. According to data from the World Health Organization (WHO), the average cost of a single dental implant in the U.S. ranges from US$ 3,000 to US$ 4,500. Similarly, the average cost of a bone graft procedure is between US$ 2,000 to US$ 5,000. These costs place such advanced treatment options out of reach for many patients, especially those from low and middle-income communities globally. The financial burden of expensive dental treatments discourages many from seeking regenerative care, even if they have severe dental issues. This poses a huge barrier in expanding access to innovative tooth regeneration therapies.

Market Opportunities: Tissue engineering approach for whole tooth reconstruction

Tissue engineering approach for whole tooth reconstruction has the potential to revolutionize the tooth regeneration market. The conventional method of dental implants and bridges have limitations and issues related to biocompatibility. The tissue engineering approach aims to biologically reconstruct a tooth using stem cells and biocompatible scaffolds which can integrate seamlessly within the oral environment. This promising technique closely mimics the natural development of teeth.

The approach involves extracting stem cells from the patient's own dental pulp or oral mucosa. These stem cells are grown in the laboratory and placed onto a porous biodegradable scaffold made of materials like silk, collagen, or hydroxyapatite. This bio-engineered tooth root or crown is then implanted into the empty socket in the jaw bone where it can revascularize and develop innate neural connections. Over a period of six months to a year, the scaffold degrades and gets replaced by the patient's own living dental tissues like dentin, pulp and enamel, eventually forming a fully functional natural tooth.

Discover high revenue pocket segments and roadmap to it: Request sample copy

By Application: Enamel Drives Demand in the Tooth Regeneration Application Segment

In terms of application, enamel is expected to contribute the highest share of 60.0% in 2024 owing to its prominence and importance in dental health. Enamel is the hardest substance in the human body and forms the protective visible exterior of teeth. It is responsible for resisting decay and protecting the inner layers of the tooth from trauma. As such, there is significant focus within the field of tooth regeneration on developing treatments and solutions targeted towards enamel. Key drivers of growth within this segment include the high prevalence of enamel defects such as cracks, chips, and erosion due to factors like aging, acids in food and drinks, and injuries. Enamel does not regenerate on its own, so innovations that can stimulate enamel growth or replacement are keenly sought after. Promising research into therapies involving enamel matrix proteins, gene therapies, tissue engineering, and stem cells hold potential to transform the management of enamel defects and drive the segment's growth.

By Population Demographics: Geriatrics Seek Out Tooth Regeneration Options

Within the demographic segment of the tooth regeneration market, the geriatrics population is expected to contribute the highest share of 40.12% in 2024. As people age, dental health declines progressively due to factors like wear and tear, chronic conditions, and decreased regenerative capacity of the body. Tooth loss is more prevalent among geriatrics due to issues like periodontal disease, exposed roots after gum recession, and untreated caries. Unfortunately, traditional dental treatments like dentures, bridges, and implants often do not provide a natural feel or function and can be less than ideal for older individuals. In 2021, the World Bank reported that 65% of the total population consisted of adults. Additionally, the World Health Organization (WHO) estimates that periodontal diseases are expected to impact approximately 19% of the adult population worldwide, amounting to over 1.0 billion cases.

Regional Insights

To learn more about this report, Request sample copy

North America has dominated the global tooth regeneration market for the past decade owing to significant research and development activities in the field of regenerative dentistry. The U.S. alone accounts for over 40.2% of the region's market share due to heavy investments by both public and private players. It has emerged as a pioneer in stem cell therapies and tissue engineering-based approaches for tooth regeneration. The presence of leading academic institutes and global medical device companies have created a robust ecosystem that drives innovation.

However, the Asia Pacific region is witnessing the fastest growth and is emerging as the new hotspot for tooth regeneration technologies. In particular, China has seen exponential growth fueled by increasing dental issues among its working population and rising medical tourism. The Chinese government is strongly supporting the development of innovative solutions through favorable research policies and funding. This has attracted major investments from multinational firms looking to expand in the high-potential market.

Moreover, growing dental expertise and advanced healthcare infrastructure have made countries like Japan, South Korea, and India important regional hubs. Low-cost operations and availability of skilled professionals provide significant cost advantages. Local giants are also entering partnerships to facilitate technology transfers and commercialization. The large patient pool and rising awareness about oral healthcare presents a massive untapped market opportunity. Overall, Asia Pacific's performance can be attributed to rapid economic development, expansions by global industry players, and growing dental expenditures.

Market Report Scope

Tooth Regeneration Industry News

• In February 2024, Toregem Biopharma Co., a pharmaceutical startup based in Osaka, revealed its plans to initiate clinical trials shortly for an innovative drug designed to promote the regeneration of teeth in humans. Supported by Kyoto University, the company has demonstrated promising results in animal studies and anticipates a significant advancement in human trials by 2030, offering the prospect of transforming dental healthcare.
• In January 2023, RevBio Inc., a medical device company, obtained approval from the Italian Ministry of Health to initiate a pilot clinical trial involving 15 patients. The trial aims to evaluate the efficacy of Tetranite, the company's adhesive biomaterial, in bone regeneration within the mandibular and maxillary dental arches.
• In October 2022, WuXi Biologics, global Contract Research Development and Manufacturing Organization and Toregem BioPharma, a biopharma company inked a Memorandum of Understanding (MoU) to establish a strategic partnership for the development of TRG035. This regenerative drug targets USAG-1 and is intended for the treatment of congenital adentia, a dental disorder.
• In June 2022, VideaHealth, a provider of dental artificial intelligence (AI) solutions, announced the acquisition of a Medical Device Establishment License (MDEL) from Health Canada for its product, Videa Caries Assist. This AI-powered algorithm specializes in dental caries (cavity) detection. VideaHealth's AI and software solutions empower dentists to enhance their analysis of patient X-rays, streamline reimbursement processes, and offer improved transparency and accuracy in treatment recommendations.

*Definition: The tooth regeneration market involves products and therapies that promote the natural regeneration and regrowth of teeth. This growing market includes stem cell therapies, biomaterials, and regenerative medicines that can help replace damaged or missing teeth by stimulating the body's own reparative processes. The goal is to develop clinically proven treatments that can restore teeth without requiring dental implants, crowns, bridges or dentures through non-surgical and minimally invasive approaches.

Market Segmentation

•  Application Insights (Revenue, USD BN, 2019 - 2031)
  • Enamel
  • Dentin
  • Pulp
•  Population Demographics Insights (Revenue, USD BN, 2019 - 2031)
  • Geriatrics
  • Middle Aged
  • Adult
  • Others
• Regional Insights (Revenue, USD BN, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
    • Pradeep Tripathi
• Key Players Insights
  • Straumann Holding AG
  • DENTSPLY Sirona Inc.
  • Zimmer Biomet Holdings, Inc.
  • Integra LifeSciences Holdings Corporation
  • Datum Dental Ltd.
  • Institut Straumann AG
  • Unilever
  • Procter & Gamble
  • Young Innovations, Inc.
  • 3M Company
  • Ocata Therapeutics Inc. (a subsidiary of Astellas Pharma Inc.)
  • CryoLife, Inc.
  • BioMimetic Therapeutics, LLC (a subsidiary of Wright Medical Group N.V.)
  • Cook Medical
  • StemCells, Inc.
  • TheraCell, Inc.
  • CollPlant Holdings Ltd.